Key F Inancial Inc Immuno Gen, Inc. Transaction History

Key F Inancial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	BUY	$4.75 - $7.5 $57 - $90	12 Added 1.5%	812 $6,000
Q4 2020 Jan 29, 2021	BUY	$3.7 - $7.66 $2,960 - $6,128	800 New	800 $5,000
Q2 2020 Aug 07, 2020	SELL	$3.32 - $5.34 $2,656 - $4,272	-800 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$2.12 - $6.8 $1,696 - $5,440	800 New	800 $3,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

Stay updated on Key F Inancial Inc with notifications on news.